Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Biotechnol ; 18(3): 343-5, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10700154

ABSTRACT

Bacteria belonging to the order Actinomycetales produce most microbial metabolites thus far described, several of which have found applications in medicine and agriculture. However, most strains were discovered by their ability to produce a given molecule and are, therefore, poorly characterized physiologically and genetically. Thus, methodologies for genetic manipulation of actinomycetes are not available and efficient tools have been developed for just a few strains. This constitutes a serious limitation to applying molecular genetics approaches to strain development and structural manipulation of microbial metabolites. To overcome this hurdle, we have developed bacterial artificial chromosomes (BAC) that can be shuttled among Escherichia coli, where they replicate autonomously, and a suitable Streptomyces host, where they integrate site-specifically into the chromosome. The existence of gene clusters and of genetically amenable host strains, such as Streptomyces coelicolor or Streptomyces lividans, makes this a sensible approach. We report here that 100 kb segments of actinomycete DNA can be cloned into these vectors and introduced into genetically accessible S. lividans, where they are stably maintained in integrated form in its chromosome.


Subject(s)
Actinomycetales/genetics , Actinomycetales/metabolism , Anti-Bacterial Agents/biosynthesis , Chromosomes, Bacterial , Blotting, Southern , Escherichia coli/genetics , Gene Library , Genetic Engineering/methods , Models, Genetic , Plasmids/genetics , Streptomyces/genetics
2.
Mol Microbiol ; 22(1): 43-51, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8899707

ABSTRACT

Using a cell-free protein-synthesis system, we have established that the elongation factor (EF) Tu (EF-Tu) of the actinomycete Planobispora rosea, the producer of the thiazolyl peptide GE2270, a specific EF-Tu inhibitor, is highly resistant to its own antibiotic, while it is completely inhibited by kirromycin, which is another inhibitor of this factor. P. rosea was found to possess a single tuf gene, located between fus and rpsJ, encoding other components of the protein-synthesis machinery. The P. rosea tuf gene was expressed as a translational fusion to malE in Escherichia coli, and the resulting EF-Tu with an N-terminal Gly-Met extension was able to promote poly(U)-directed poly(Phe) synthesis in cell-free systems. This activity was not affected by GE2270, and the recombinant protein was incapable of binding the antibiotic, indicating that the P. rosea EF-Tu is intrinsically resistant to this inhibitor. Inspection of the translated tuf sequence revealed a number of amino acid substitutions in highly conserved positions. These residues, which are likely to be involved in conferring GE2270 resistance, map in EF-Tu domain II, as do the only two known mutations conferring resistance to this class of thiazolyl peptides in Bacillus subtilis.


Subject(s)
ATP-Binding Cassette Transporters , Actinomycetales/physiology , Anti-Bacterial Agents/pharmacology , Escherichia coli Proteins , Monosaccharide Transport Proteins , Peptide Elongation Factor Tu/antagonists & inhibitors , Peptides, Cyclic/pharmacology , Periplasmic Binding Proteins , Amino Acid Sequence , Carrier Proteins/biosynthesis , Carrier Proteins/genetics , Cloning, Molecular , Conserved Sequence , Dose-Response Relationship, Drug , Drug Resistance, Microbial/genetics , Escherichia coli/genetics , Genes, Bacterial , Maltose-Binding Proteins , Models, Molecular , Molecular Sequence Data , Mutation , Peptide Elongation Factor Tu/biosynthesis , Peptide Elongation Factor Tu/genetics , Pyridones/pharmacology , Recombinant Fusion Proteins/biosynthesis , Recombinant Proteins/biosynthesis , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Thiazoles/pharmacology
3.
Res Microbiol ; 144(8): 665-72, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8140285

ABSTRACT

Actinomycetes have the genetic capability to synthesize many different biologically active secondary metabolites and of these compounds, antibiotics predominate in therapeutic and commercial importance. Intensive research often centres on the use of molecular techniques to investigate the physiology and genetics of antibiotic biosynthesis with a view to improving production. The isolation of clones of Streptomyces hygroscopicus, the producer of geldanamycin, which synthesizes geldanamycin in S. lividans, is reported. Molecular approaches using genes for elongation factors (tuf) were used in attempts to increase the fermentation yield of kirromycin, whilst probes for aphD and sph, genes for streptomycin phosphotransferases, were used to gather information on streptomycin genes in soil. Actinomycete populations in soil and earthworms may help in developing a strategy for discovering additional antimicrobials in soil. The relationship of proline metabolism to the secondary metabolite undecylprodigiosin and the carbon regulation of spiramycin biosynthesis in S. ambofaciens is also reported.


Subject(s)
Actinomycetales/metabolism , Anti-Bacterial Agents/biosynthesis , Streptomyces/metabolism , Tobramycin/biosynthesis , Drug Resistance, Microbial , Glycerol/pharmacology , In Vitro Techniques , Lactams, Macrocyclic , Prodigiosin/analogs & derivatives , Prodigiosin/biosynthesis , Pyridones/metabolism , Spiramycin/biosynthesis , Streptomyces/drug effects
5.
Gene ; 90(1): 31-41, 1990 May 31.
Article in English | MEDLINE | ID: mdl-2199329

ABSTRACT

Biochemical and genetic data indicate that in Streptomyces coelicolor A3(2) the majority of the genes involved in the biosynthesis of histidine are clustered in a small region of the chromosome [Carere et al., Mol. Gen. Genet. 123 (1973) 219-224; Russi et al., Mol. Gen. Genet. 123 (1973) 225-232]. To investigate the structural organization and the regulation of these genes, we have constructed genomic libraries from S. coelicolor A3(2) in pUC vectors. Recombinant clones were isolated by complementation of an Escherichia coli hisBd auxotroph. A recombinant plasmid containing a 3.4-kb fragment of genomic DNA was further characterized. When cloned in the plasmid vector, pIJ699, this fragment was able to complement S. coelicolor A3(2) hisB mutants. Overlapping clones spanning a 15-kb genomic region were isolated by screening other libraries with labeled DNA fragments obtained from the first clone. Derivative clones were able to complement mutations in four different cistrons of the his cluster of S. coelicolor A3(2). Nucleotide sequence analysis of a 4-kb region allowed the identification of five ORFs which showed significant homology with the his gene products of E. coli. The order of the genes in S. coelicolor A3(2) (5'--hisD-hisC-hisBd-hisH-hisA-3') is the same as in the his operon of E. coli.


Subject(s)
Genes, Fungal , Histidine , Streptomyces/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Escherichia coli/genetics , Genetic Complementation Test , Molecular Sequence Data , Plasmids , Restriction Mapping
SELECTION OF CITATIONS
SEARCH DETAIL
...